Immune checkpoint therapy has become the first widely adopted immunotherapy for patients
with late stage malignant melanoma, with potential for a wide range of cancers. While some …

Immunotherapy has demonstrated great clinical success in certain cancers, driven primarily
by immune checkpoint blockade and adoptive cell therapies. Immunotherapy can elicit …

Immune checkpoint inhibitors (ICIs) have ushered in a new era of cancer therapy; however,
ICIs are only effective in selective patients. The efficacy of ICIs is closely related to the tumor …

According to the difference in temperature, thermotherapy can be divided into thermal
ablation and mild hyperthermia. The main advantage of thermal ablation is that it can …

In the quest for cancer treatment modalities with greater effectiveness, the combination of
tumor immunotherapy and nanoparticle-based hyperthermia has emerged as a promising …

Immune checkpoint blockade (ICB) comprising monoclonal antibodies (mAbs) against
immune 'checkpoints', such as CTLA-4 and the PD1/PDL1 axis have dramatically improved …

Although current anticancer immunotherapies using immune checkpoint inhibitors (ICIs)
have been reported with a high clinical success rate, numerous patients still bear …

Background Within the field of oncotherapy, research interest regarding immunotherapy has
risen to the point that it is now seen as a key application. However, inherent disadvantages …

Immunotherapy has revolutionized the treatment of patients with cancer. However,
promoting antitumour immunity in patients with tumours that are resistant to these therapies …

The past decades have witnessed hyperthermia therapy (HTT) as an emerging strategy
against malignant tumors. Nanomaterial‐based photothermal therapy (PTT) and magnetic …